{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus Palyam : Questions médicales les plus fréquentes",
"headline": "Virus Palyam : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus Palyam : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-10",
"dateModified": "2025-05-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus Palyam"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Orbivirus",
"url": "https://questionsmedicales.fr/mesh/D018163",
"about": {
"@type": "MedicalCondition",
"name": "Orbivirus",
"code": {
"@type": "MedicalCode",
"code": "D018163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.223.719.550"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus Palyam",
"alternateName": "Palyam Virus",
"code": {
"@type": "MedicalCode",
"code": "D030081",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Duncan R Smith",
"url": "https://questionsmedicales.fr/author/Duncan%20R%20Smith",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand. duncan_r_smith@hotmail.com."
}
},
{
"@type": "Person",
"name": "Atitaya Hitakarun",
"url": "https://questionsmedicales.fr/author/Atitaya%20Hitakarun",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Nitwara Wikan",
"url": "https://questionsmedicales.fr/author/Nitwara%20Wikan",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Sittiruk Roytrakul",
"url": "https://questionsmedicales.fr/author/Sittiruk%20Roytrakul",
"affiliation": {
"@type": "Organization",
"name": "National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathum Thani, 12120, Thailand."
}
},
{
"@type": "Person",
"name": "Ronaldo Mohana-Borges",
"url": "https://questionsmedicales.fr/author/Ronaldo%20Mohana-Borges",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Structural Biotechnology and Bioengineering, Biophysics Institute Carlos Chagas Filho, Lab C0-36ss, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. mohana@biof.ufrj.br."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA as a potential diagnostic tool for prostate cancer: a systematic review and meta-analysis.",
"datePublished": "2022-11-22",
"url": "https://questionsmedicales.fr/article/36323640",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/1354750X.2022.2142293"
}
},
{
"@type": "ScholarlyArticle",
"name": "The long noncoding RNA",
"datePublished": "2023-02-27",
"url": "https://questionsmedicales.fr/article/36923129",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpls.2023.1139143"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Landscape of Noncoding RNA in Pulmonary Hypertension.",
"datePublished": "2022-06-07",
"url": "https://questionsmedicales.fr/article/35740920",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/biom12060796"
}
},
{
"@type": "ScholarlyArticle",
"name": "Protective Effect of Long Noncoding RNA OXCT1-AS1 on Doxorubicin-Induced Apoptosis of Human Myocardial Cells by the Competitive Endogenous RNA Pattern.",
"datePublished": "2024-07-01",
"url": "https://questionsmedicales.fr/article/38958296",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.36660/abc.20230675"
}
},
{
"@type": "ScholarlyArticle",
"name": "As a novel prognostic model for breast cancer, the identification and validation of telomere-related long noncoding RNA signatures.",
"datePublished": "2024-09-11",
"url": "https://questionsmedicales.fr/article/39261898",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12957-024-03514-2"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Virus à ARN double brin",
"item": "https://questionsmedicales.fr/mesh/D000086122"
},
{
"@type": "ListItem",
"position": 5,
"name": "Reoviridae",
"item": "https://questionsmedicales.fr/mesh/D012087"
},
{
"@type": "ListItem",
"position": 6,
"name": "Orbivirus",
"item": "https://questionsmedicales.fr/mesh/D018163"
},
{
"@type": "ListItem",
"position": 7,
"name": "Virus Palyam",
"item": "https://questionsmedicales.fr/mesh/D030081"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus Palyam - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus Palyam",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus Palyam",
"description": "Comment diagnostiquer une infection par le virus Palyam ?\nQuels tests sont utilisés pour le virus Palyam ?\nLes symptômes aident-ils au diagnostic ?\nLe virus Palyam est-il identifiable par culture ?\nY a-t-il des marqueurs spécifiques pour le virus Palyam ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=RNA,+Long+Noncoding&page=8#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus Palyam",
"description": "Quels sont les symptômes courants du virus Palyam ?\nLes symptômes varient selon les individus ?\nLe virus Palyam cause-t-il des complications graves ?\nLes symptômes apparaissent-ils rapidement ?\nY a-t-il des symptômes spécifiques aux enfants ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=RNA,+Long+Noncoding&page=8#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus Palyam",
"description": "Comment prévenir l'infection par le virus Palyam ?\nLes vaccins existent-ils pour le virus Palyam ?\nLes mesures d'hygiène aident-elles à prévenir l'infection ?\nLes moustiquaires sont-elles efficaces contre le virus Palyam ?\nLes voyages dans certaines zones augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=RNA,+Long+Noncoding&page=8#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus Palyam",
"description": "Quel est le traitement principal pour le virus Palyam ?\nLes antibiotiques sont-ils efficaces contre le virus Palyam ?\nDes antiviraux sont-ils disponibles pour ce virus ?\nComment gérer les symptômes du virus Palyam ?\nLe repos est-il recommandé lors d'une infection ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=RNA,+Long+Noncoding&page=8#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus Palyam",
"description": "Quelles sont les complications possibles du virus Palyam ?\nLes complications sont-elles fréquentes ?\nComment les complications sont-elles traitées ?\nLes complications affectent-elles la récupération ?\nY a-t-il des facteurs de risque pour les complications ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=RNA,+Long+Noncoding&page=8#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus Palyam",
"description": "Quels sont les principaux facteurs de risque pour le virus Palyam ?\nLes personnes âgées sont-elles plus à risque ?\nLes voyageurs sont-ils à risque d'infection ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?\nY a-t-il des occupations à risque pour le virus Palyam ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=RNA,+Long+Noncoding&page=8#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par le virus Palyam ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et la détection de l'ARN viral par PCR."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le virus Palyam ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et la PCR sont couramment utilisés pour identifier le virus."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques peuvent orienter le diagnostic, mais ne suffisent pas seuls."
}
},
{
"@type": "Question",
"name": "Le virus Palyam est-il identifiable par culture ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La culture du virus est difficile et rarement utilisée pour le diagnostic clinique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs spécifiques pour le virus Palyam ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anticorps spécifiques peuvent être détectés, mais ils ne sont pas exclusifs au virus."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du virus Palyam ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs musculaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon les individus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier d'une personne à l'autre."
}
},
{
"@type": "Question",
"name": "Le virus Palyam cause-t-il des complications graves ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques peuvent survenir, bien que rares."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître rapidement, généralement dans les 3 à 7 jours après infection."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux enfants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes similaires, mais souvent moins sévères."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le virus Palyam ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'évitement des piqûres d'insectes et l'utilisation de répulsifs."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils pour le virus Palyam ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin commercialisé contre le virus Palyam."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène aident-elles à prévenir l'infection ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mesures d'hygiène appropriées peuvent réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les moustiquaires sont-elles efficaces contre le virus Palyam ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation de moustiquaires peut aider à prévenir les piqûres d'insectes."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines zones augmentent-ils le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques augmente le risque d'infection par le virus."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour le virus Palyam ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique; le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre le virus Palyam ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales comme le Palyam."
}
},
{
"@type": "Question",
"name": "Des antiviraux sont-ils disponibles pour ce virus ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antiviraux spécifiques pour traiter le virus Palyam."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes du virus Palyam ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des symptômes inclut des analgésiques et des antipyrétiques pour la fièvre."
}
},
{
"@type": "Question",
"name": "Le repos est-il recommandé lors d'une infection ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le repos est conseillé pour aider le corps à combattre l'infection."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du virus Palyam ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des troubles neurologiques et des syndromes hémorragiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications graves sont rares, mais peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles traitées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement des complications est symptomatique et peut nécessiter des soins intensifs."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la récupération ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent prolonger le temps de récupération et affecter la santé globale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs de risque pour les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées ou âgées peuvent avoir un risque accru de complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour le virus Palyam ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à des zones endémiques et un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus susceptibles de développer des complications."
}
},
{
"@type": "Question",
"name": "Les voyageurs sont-ils à risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs vers des régions où le virus est endémique courent un risque accru."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles ont un risque accru de développer des formes graves de l'infection."
}
},
{
"@type": "Question",
"name": "Y a-t-il des occupations à risque pour le virus Palyam ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs en milieu rural ou en contact avec des animaux peuvent être à risque."
}
}
]
}
]
}
To identify consistently expressed lncRNAs and suitable lncRNAs with high sensitivity and specificity from multiple independent studies as potential biomarkers for PCa diagnostics....
We searched multiple electronic databases including PubMed, Web of Science, EMBASE, Cochrane Library, CNKI, CQVIP, Wanfang, and CBMdisc for studies published up to July 2022. The quality of the includ...
Among the 26 included studies, 2 circulating lncRNAs (PCA3 and MALAT-1) were reported 3 or more times in PCa patients versus non-PCa patients. In further analysis, the areas under the curve of the sum...
Based on the current evidence, PCA3 and MALAT-1 are reliable lncRNAs for the diagnosis of PCa....
The transcriptome of pulmonary hypertension (PH) is complex and highly genetically heterogeneous, with noncoding RNA transcripts playing crucial roles. The majority of RNAs in the noncoding transcript...
The anthracycline chemotherapeutic antibiotic doxorubicin (DOX) can induce cumulative cardiotoxicity and lead to cardiac dysfunction. Long non-coding RNAs (lncRNAs) can function as important regulator...
This study aims to investigate the functional role and molecular mechanism of lncRNA OXCT1 antisense RNA 1 (OXCT1-AS1) in DOX-induced myocardial cell injury in vitro....
Human cardiomyocytes (AC16) were stimulated with DOX to induce a myocardial cell injury model. OXCT1-AS1, miR-874-3p, and BDH1 expression in AC16 cells were determined by RT-qPCR. AC16 cell viability ...
OXCT1-AS1 expression was decreased in DOX-treated AC16 cells. Overexpression of OXCT1-AS1 reversed the reduction of cell viability and promotion of cell apoptosis caused by DOX. OXCT1-AS1 is competiti...
LncRNA OXCT1-AS1 protects human myocardial cells AC16 from DOX-induced apoptosis via the miR-874-3p/BDH1 axis....
Telomeres are a critical component of chromosome integrity and are essential to the development of cancer and cellular senescence. The regulation of breast cancer by telomere-associated lncRNAs is not...
We obtained RNA-seq data, pertinent clinical data, and a list of telomere-associated genes from the cancer genome atlas and telomere gene database, respectively. We subjected differentially expressed ...
We developed a risk model for the 14-TRL, and we used ROC curves to demonstrate how accurate the model is. The model may be a standalone prognostic predictor for patients with breast cancer, according...
As a possible biomarker, the proposed 14-TRL signature could be utilized to evaluate clinical outcomes and treatment efficacy in breast cancer patients....
Doxorubicin (DOX) often causes acute or chronic cardiotoxicity during its application. LncRNA RMRP has been reported to be associated with several biological processes, such as cartilage-hair hypoplas...
Long non‑coding RNAs (lncRNAs) represent a class of versatile molecules that exhibit the potential to regulate gene expression at various levels, namely transcriptional, post‑transcriptional and epige...
Bladder cancer (BC) is the most common malignant tumour of the urinary system and one of the leading causes of cancer-related death. Cuproptosis is a novel form of programmed cell death, and its mecha...
Numerous studies have probed the deregulation of the long noncoding RNA AB073614 and FER1L4, which have been discovered in a variety of cancers. However, the precise expression pattern of these lncRNA...
The expression levels of lncRNA AB073614 and FER1L4 were assessed in 30 newly diagnosed AML patients and 12 healthy individuals using quantitative reverse transcription-polymerase chain reaction techn...
A significant upregulation of AB073614 was observed in AML patients compared to the control group (p < 0.05). Moreover, a notable increase in AB073614 expression levels coincided with a significant re...
The present study indicates that AB073614 and FER1L4 might serve as prognosis biomarkers in AML patients. However, further detailed examinations in this field are warranted. It is proposed that the li...
Myocardial infarction (MI) is severe heart disease leading to the death worldwide. Long noncoding RNAs (lncRNAs) play a vital role in progression of numerous heart diseases. In the present study, we e...